Compare BioNTech SE - ADR (BNTX) vs T Rowe Price Group Inc (TROW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs T Rowe Price Group Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while T Rowe Price Group Inc trades at $116.99 (market cap $24.26B). The key difference: BioNTech SE - ADR and T Rowe Price Group Inc are close in size by market cap, and T Rowe Price Group Inc pays a 4.57% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | TROW | |
|---|---|---|
Market Cap | $23.31B | $24.26B |
Sector | Health | Financials |
52-Week High | $119.34 | $121.68 |
52-Week Low | $83.89 | $86.19 |
Enterprise Value | $6.60B | $21.46B |
Dividend Yield | — | 4.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About T Rowe Price Group Inc
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →
